Vascular in situ tissue engineering (TE) is an approach that uses bioresorbable grafts to
induce endogenous regeneration of damaged blood vessels. The evaluation of newly …

Several patient groups undergoing small-diameter (< 6 mm) vessel bypass surgery have
limited autologous vessels for use as grafts. Tissue-engineered vascular grafts (TEVG) have …

Autologous or synthetic vascular grafts are used routinely for providing access in
hemodialysis or for arterial bypass in patients with cardiovascular disease. However, some …

Cardiovascular disease is a primary cause of mortality worldwide, and patients often require
bypass surgery that utilizes autologous vessels as conduits. However, the limited availability …

Vascular tissue engineering has made prodigious progress in recent years by converging
multidisciplinary approaches. Latest technological advancements foster the development of …

Foreign materials often used in cardiovascular surgery may cause unwanted side effects
and reduced growth potential. To resolve these problems, we have designed a tissue …

Blood vessels transport blood to deliver oxygen and nutrients. Vascular diseases such as
atherosclerosis may result in obstruction of blood vessels and tissue ischemia. These …

Bioengineering an effective, small diameter (< 6 mm) artificial vascular graft for use in
bypass surgery when autologous grafts are unavailable remains a persistent challenge …

Highlights•There is increasing demand for small diameter blood vessels as replacement
grafts.•Major roadblocks in engineered vascular grafts: cell sources and in vivo …

Pathologies related to the cardiovascular system are the leading causes of death worldwide.
One of the main treatments is conventional surgery with autologous transplants. Although …